And Just Like That, We Have Another Double. iBio (IBIO).
$5.35 With 11 Million Shares Traded and it's Not Even 10:00!
Where is Citius Pharma (CTXR) in the FDA Approval Process?
We have a number of subscribers asking for an update on the FDA approval process for Mino-Lok. In layman's term (assuming approval)...
Adding iBIO (IBIO) $2.27 to CoronaVirus Watch List.
SUPERBUG NEWS: Is this the next Robinhood target?
"Don't get ready, don't aim - just fire." Sal the...
2020 Biotech Portfolio Soars 55%, We’re Amazed.
1. Yep, We Are Absolutely Amazed At The Biotech Stock Review’s 2020 Watch List Performance – Especially In The Light Of –...
Citius (CTXR) CEO Myron Holubiak Live on TV, 1:20 Today, June 30th.
VIDEO: Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
Citius Pharma (CTXR) On The Move.
One Of Our Top 5 Biotech Picks For 2020 Up 23% Yesterday, Indicating Up Another 24% This Morning. Inquiring Minds Want...
Meet The Billion-Dollar Family Company That Makes Purell (Forbes).
Jerry and Goldie Lippman cofounded Gojo in Akron, Ohio, in 1946.
Forbes 3/20/2020
Panic buying is...
Corona Craziness Continues. Immuron (IMRN) Gains 10-Fold or 1000%, in 3 Months!
Too bad we don’t trade for a living! We don’t even use real-time quotes, LOL. $2.57 to $27.13, from March 3rd ...
11:00 AM Webinar Today, Checkpoint Therapeutics (CKPT) CEO James Olivero.
Virtually meet the CEO of Checkpoint, James Oliviero, on May 28th at 11 am for an update on their two most advanced programs.
Immunomedics (IMMU) $33 | Raising Price Potential to $60. American BriVision (ABVC) $3.00 |...
We Are Raising the Price Potential of Immunomedics (IMMU) to $60, Highest on the Street, and Initiating Coverage on Another $3.00 Medical...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
